Fort Washington Investment Advisors Inc. OH Sells 159,820 Shares of Doximity, Inc. (NASDAQ:DOCS)

Fort Washington Investment Advisors Inc. OH trimmed its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 39.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 248,000 shares of the company’s stock after selling 159,820 shares during the period. Fort Washington Investment Advisors Inc. OH owned approximately 0.13% of Doximity worth $13,241,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in DOCS. UMB Bank n.a. raised its position in Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after purchasing an additional 235 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after buying an additional 603 shares in the last quarter. Quarry LP raised its holdings in shares of Doximity by 101.2% in the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after buying an additional 131,253 shares in the last quarter. Morse Asset Management Inc bought a new position in shares of Doximity during the 3rd quarter worth approximately $46,000. Finally, GAMMA Investing LLC boosted its stake in Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after buying an additional 412 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Trading Up 0.9 %

Shares of NASDAQ DOCS opened at $56.00 on Thursday. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $61.75. The firm’s 50-day moving average is $53.59 and its 200-day moving average is $43.13. The firm has a market capitalization of $10.45 billion, a PE ratio of 64.37, a price-to-earnings-growth ratio of 4.25 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). The business had revenue of $136.83 million during the quarter, compared to the consensus estimate of $127.05 million. Doximity had a net margin of 33.69% and a return on equity of 19.79%. During the same period in the previous year, the business posted $0.18 earnings per share. As a group, equities research analysts anticipate that Doximity, Inc. will post 0.88 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Barclays lifted their price objective on Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a report on Monday, November 11th. Bank of America boosted their price target on shares of Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Canaccord Genuity Group reaffirmed a “hold” rating and set a $60.00 price objective (up previously from $40.00) on shares of Doximity in a report on Wednesday, November 13th. Stephens started coverage on Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 price target on the stock. Finally, Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and raised their price target for the company from $33.00 to $53.00 in a report on Thursday, November 14th. Thirteen research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Doximity presently has a consensus rating of “Hold” and a consensus target price of $53.12.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.